Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Peters-Golden

Showing results (161-170 of 171) with videos related to

Pageof 18
Sort By:
Science Translational Medicine|August 30, 2013
Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertensionWen Tian, Xinguo Jiang, Rasa Tamosiuniene, et al.
Annals of the Rheumatic Diseases|November 9, 2021
Antifibrotic factor KLF4 is repressed by the miR-10/TFAP2A/TBX5 axis in dermal fibroblasts: insights from twins discordant for systemic sclerosisMaya Malaab, Ludivine Renaud, Naoko Takamura, et al.
JCI Insight|October 18, 2019
Alveolar macrophage secretion of vesicular SOCS3 represents a platform for lung cancer therapeuticsJennifer M Speth, Loka R Penke, Joseph D Bazzill, et al.
The Journal of Clinical Investigation|May 27, 2010
The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and miceKristy A Bauman, Scott H Wettlaufer, Katsuhide Okunishi, et al.
Hypertension (Dallas, Tex. : 1979)|November 13, 2015
Leukotriene B4 Activates Pulmonary Artery Adventitial Fibroblasts in Pulmonary HypertensionJin Qian, Wen Tian, Xinguo Jiang, et al.
Scientific Reports|January 11, 2013
Murine colitis is mediated by vimentinNirit Mor-Vaknin, Maureen Legendre, Yue Yu, et al.
Science Translational Medicine|May 12, 2017
Leukotriene B<sub>4</sub> antagonism ameliorates experimental lymphedemaWen Tian, Stanley G Rockson, Xinguo Jiang, et al.
Frontiers in Pharmacology|March 21, 2022
Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators-What is the Evidence so far?Nils Helge Schebb, Hartmut Kühn, Astrid S Kahnt, et al.
Circulation|August 30, 2019
Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal TransformationWen Tian, Xinguo Jiang, Yon K Sung, et al.
Biorxiv : the Preprint Server for Biology|April 24, 2023
GTP signaling links metabolism, DNA repair, and responses to genotoxic stressWeihua Zhou, Zitong Zhao, Angelica Lin, et al.
Pageof 18

Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
Science Translational Medicine|August 30, 2013
Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertensionWen Tian, Xinguo Jiang, Rasa Tamosiuniene, et al.
Annals of the Rheumatic Diseases|November 9, 2021
Antifibrotic factor KLF4 is repressed by the miR-10/TFAP2A/TBX5 axis in dermal fibroblasts: insights from twins discordant for systemic sclerosisMaya Malaab, Ludivine Renaud, Naoko Takamura, et al.
JCI Insight|October 18, 2019
Alveolar macrophage secretion of vesicular SOCS3 represents a platform for lung cancer therapeuticsJennifer M Speth, Loka R Penke, Joseph D Bazzill, et al.
The Journal of Clinical Investigation|May 27, 2010
The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and miceKristy A Bauman, Scott H Wettlaufer, Katsuhide Okunishi, et al.
Hypertension (Dallas, Tex. : 1979)|November 13, 2015
Leukotriene B4 Activates Pulmonary Artery Adventitial Fibroblasts in Pulmonary HypertensionJin Qian, Wen Tian, Xinguo Jiang, et al.
Scientific Reports|January 11, 2013
Murine colitis is mediated by vimentinNirit Mor-Vaknin, Maureen Legendre, Yue Yu, et al.
Science Translational Medicine|May 12, 2017
Leukotriene B<sub>4</sub> antagonism ameliorates experimental lymphedemaWen Tian, Stanley G Rockson, Xinguo Jiang, et al.
Frontiers in Pharmacology|March 21, 2022
Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators-What is the Evidence so far?Nils Helge Schebb, Hartmut Kühn, Astrid S Kahnt, et al.
Circulation|August 30, 2019
Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal TransformationWen Tian, Xinguo Jiang, Yon K Sung, et al.
Biorxiv : the Preprint Server for Biology|April 24, 2023
GTP signaling links metabolism, DNA repair, and responses to genotoxic stressWeihua Zhou, Zitong Zhao, Angelica Lin, et al.
Pageof 18